Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
Clinical trial NCT01428661 · COMPLETED
Trial details
- NCT number
- NCT01428661
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.